BASTIAN Jolie Anne,CHEN Jiehao,COHEN Jeffrey Daniel,HENRY James Robert,MCMILLEN William Thomas,REAMAN Bradley Earl,RUBIO Almudena,SALL Daniel Jon,ZHAO Gaiying
申请号：
SI201730252
公开号：
SI3468965T1
申请日:
2017.05.31
申请国别(地区):
SI
年份:
2020
代理人:
摘要：
The present invention relates to certain novel 2,3-dihydro-1H-indole compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, more particularly for the treatment of cancer selected from the group consisting of melanoma, acute myeloid leukemia, chronic lymphocytic leukemia, colorectal cancer, breast cancer, lung cancer, ovarian cancer, fallopian tube carcinoma, primary peritoneal carcinoma, cervical cancer, gastric cancer, liver cancer, pancreatic cancer, thyroid cancer, glioma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma.
